Healthcare, Real Estate, Industrials Sep 21, 2021 05:43 PM (GMT+8) · EqualOcean
Financial Associated Press, September 21 - Puli pharmaceutical announced that the company has recently received the listing license of bivalirudin for injection issued by the British drug and Health Products Administration (MHRA), marking that the company has the qualification to sell bivalirudin for injection in the UK, which will have a positive impact on the company's expansion of the European market.